Paroxetine Hydrochloride Suspension
Product Images NDC 31722-578

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine Hydrochloride (NDC 31722-578). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Paroxetinefigure (Paroxetinefigure1)

Paroxetinefigure (Paroxetinefigure1)
A horizontal forest plot chart showing fold change and 90% confidence intervals for pharmacokinetic variables Cmax and AUC of five interacting drugs (Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg) relative to a reference. The x-axis is labeled 'Change relative to reference' on a logarithmic scale ranging from 0.1 to 10.0.*
FDA Label Image

Paroxetinefigure2 (Paroxetinefigure2)

Paroxetinefigure2 (Paroxetinefigure2)
A pharmacokinetic graph depicting fold change and 90% confidence intervals for drug interactions with paroxetine hydrochloride suspension. It compares Cmax and AUC values relative to reference for cimetidine 300 mg three times daily, phenobarbital 100 mg once daily, phenytoin 300 mg once daily, digoxin 0.25 mg once daily, and diazepam 5 mg three times daily.*
FDA Label Image

Paroxetinefigure3 (Paroxetinefigure3)

Paroxetinefigure3 (Paroxetinefigure3)
A pharmacokinetic chart showing fold change and 90% confidence intervals for various populations relative to reference. It includes measures for renal impairment (mild, moderate, severe) with Cmax and AUC, hepatic impairment with Cmin and AUC, age groups over 65 years at different doses with Cmin, and gender (males) with Cmax and AUC. The x-axis represents change relative to reference on a logarithmic scale from 0.5 to 50.*
FDA Label Image

Paroxetinehcloscartonlabel (Paroxetinehcloscartonlabel)

Paroxetinehcloscartonlabel (Paroxetinehcloscartonlabel)
Packaging label for Paroxetine Hydrochloride Oral Suspension 10 mg/5 mL by Camber Pharmaceuticals, Inc. The label indicates a 250 mL bottle with directions to store below 25°C and shake well before use. It includes the NDC 31722-578-25 and states the product is prescription only. Manufacturing details and contact information are also present.*
FDA Label Image

Paroxetinehcloslabel (Paroxetinehcloslabel)

Paroxetinehcloslabel (Paroxetinehcloslabel)
Label for Paroxetine Hydrochloride Oral Suspension 10 mg/5 mL by Camber Pharmaceuticals, Inc. The 250 mL bottle label includes dosage strength, federal dispensing law notice, storage instructions, contact number, and manufacturer information, including Annora Pharma Pvt. Ltd., India. Features barcode and a designated batch coding area.*
FDA Label Image

Paroxetinestructure (Paroxetinestructure)

Paroxetinestructure (Paroxetinestructure)
Chemical structure diagram of paroxetine hydrochloride, the active ingredient in the product PAROXETINE HYDROCHLORIDE 10 mg/5 mL oral suspension by Camber Pharmaceuticals, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.